Amylyx Pharmaceuticals, Inc. AMLX Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported operating lease right-of-use assets in other assets of $4.88M in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets increased by 288.6% year-over-year, from $1.26M to $4.88M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets has grown at a -2.1% compound annual growth rate (CAGR), from $5.52M to $5.18M.